Tony Locantro has been a client advisor/investment manager in the stockbroking industry since 1998. He’s focused on the small cap and emerging companies with a strong interest in identifying those in the mining, biotech and industrial sectors that offer growth potential.

He also delves into the psychology of speculation and provides regular insights on a number of social media and finance related outlets.

In this episode, host Tony Locantro goes into a psychedelic state to discuss early mover Tryptamine Therapeutics (ASX:TYP) and its recent successes in an ASX sector which could soon be shooting into space.

Tune in to hear more.

 

While Tryptamine Therapeutics did not collaborate on this video, they are a Stockhead advertiser at the time of publishing.

The views, information, or opinions expressed in this video are solely those of the author and do not represent the views of Stockhead.

Stockhead has not provided, endorsed or otherwise assumed responsibility for any financial product advice contained in this article. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.

Read MoreHealth

Featured Companies

You might be interested in